JP2020527331A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020527331A5 JP2020527331A5 JP2019567602A JP2019567602A JP2020527331A5 JP 2020527331 A5 JP2020527331 A5 JP 2020527331A5 JP 2019567602 A JP2019567602 A JP 2019567602A JP 2019567602 A JP2019567602 A JP 2019567602A JP 2020527331 A5 JP2020527331 A5 JP 2020527331A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- sequence
- polypeptide according
- nucleic acid
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023140001A JP2023162355A (ja) | 2017-06-09 | 2023-08-30 | Ｃ３ｂ不活性化ポリペプチド |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1709222.2 | 2017-06-09 | ||
| GBGB1709222.2A GB201709222D0 (en) | 2017-06-09 | 2017-06-09 | C3b Inactivating Polypeptide |
| PCT/EP2018/065199 WO2018224663A1 (en) | 2017-06-09 | 2018-06-08 | C3b inactivating polypeptide |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023140001A Division JP2023162355A (ja) | 2017-06-09 | 2023-08-30 | Ｃ３ｂ不活性化ポリペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020527331A JP2020527331A (ja) | 2020-09-10 |
| JP2020527331A5 true JP2020527331A5 (enExample) | 2021-07-26 |
| JP7341897B2 JP7341897B2 (ja) | 2023-09-11 |
Family
ID=59358410
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019567602A Active JP7341897B2 (ja) | 2017-06-09 | 2018-06-08 | Ｃ３ｂ不活性化ポリペプチド |
| JP2023140001A Pending JP2023162355A (ja) | 2017-06-09 | 2023-08-30 | Ｃ３ｂ不活性化ポリペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023140001A Pending JP2023162355A (ja) | 2017-06-09 | 2023-08-30 | Ｃ３ｂ不活性化ポリペプチド |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20200277360A1 (enExample) |
| EP (1) | EP3634985A1 (enExample) |
| JP (2) | JP7341897B2 (enExample) |
| CN (1) | CN111051337A (enExample) |
| GB (1) | GB201709222D0 (enExample) |
| WO (1) | WO2018224663A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201800620D0 (en) * | 2018-01-15 | 2018-02-28 | Univ Manchester | C3b Binding Polypeptide |
| GB201821082D0 (en) | 2018-12-21 | 2019-02-06 | Gyroscope Therapeutics Ltd | Combination of complement factors i and h, and vector encoding thereof |
| GB202006789D0 (en) | 2020-05-07 | 2020-06-24 | Univ Manchester | Detection of complement proteins |
| IL299048A (en) | 2020-06-14 | 2023-02-01 | Vertex Pharma | Variants of complement factor - 1 fusion structures and preparations containing them and their uses |
| WO2022058447A1 (en) | 2020-09-16 | 2022-03-24 | The University Of Manchester | Complementome assay |
| GB202107586D0 (en) | 2021-05-27 | 2021-07-14 | Complement Therapeutics Ltd | Inhibitory nucleic acids for Factor H family proteins |
| US20240391976A1 (en) * | 2021-11-19 | 2024-11-28 | Ap Biosciences, Inc. | Bi-Functional Fusion Proteins to Complement Pathways and Method of Inhibiting Bone Resorption |
| CN114317562B (zh) * | 2022-02-22 | 2023-06-13 | 辽宁省农业科学院 | 普通菜豆镰孢菌枯萎病抗病相关蛋白的编码基因PvEXO70及应用 |
| GB202203627D0 (en) * | 2022-03-16 | 2022-04-27 | Univ Manchester | Agents for treating complement-related disorders |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999044625A1 (en) * | 1998-03-03 | 1999-09-10 | John Hopkins University | Smallpox inhibitor of complement enzymes (spice) protein and methods of inhibiting complement activation |
| GB9930659D0 (en) * | 1999-12-24 | 2000-02-16 | Bio Discovery Ltd | Inhibitors of complement activation |
| PT2044111E (pt) * | 2006-06-21 | 2014-11-12 | Univ Colorado Regents | Abordagem seletiva do fator h do complemento para o tratamento de doenças |
| MX2012014975A (es) * | 2010-06-22 | 2013-03-12 | Univ Colorado Regents | Anticuerpos al fragmento c3d de componente 3 de complemento. |
| US20160184391A1 (en) * | 2013-08-16 | 2016-06-30 | Alexion Pharmaceuticals, Inc. | Treatment of graft rejection by administering a complement inhibitor to an organ prior to transplant |
| CN104231085B (zh) * | 2013-09-05 | 2017-03-15 | 复旦大学附属肿瘤医院 | 靶向特异性补体系统抑制剂、其制备方法及应用 |
| KR102789821B1 (ko) * | 2015-03-31 | 2025-04-02 | 소리소 파마슈티컬스 인크. | 프로테아제-절단가능 링커를 갖는 펩티드 구조물 |
-
2017
- 2017-06-09 GB GBGB1709222.2A patent/GB201709222D0/en not_active Ceased
-
2018
- 2018-06-08 US US16/620,383 patent/US20200277360A1/en not_active Abandoned
- 2018-06-08 JP JP2019567602A patent/JP7341897B2/ja active Active
- 2018-06-08 CN CN201880051653.9A patent/CN111051337A/zh active Pending
- 2018-06-08 EP EP18729681.9A patent/EP3634985A1/en active Pending
- 2018-06-08 WO PCT/EP2018/065199 patent/WO2018224663A1/en not_active Ceased
-
2023
- 2023-08-30 JP JP2023140001A patent/JP2023162355A/ja active Pending
-
2024
- 2024-02-09 US US18/438,008 patent/US20240336675A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7320090B2 (ja) | 第ｖｉｉｉ因子組成物、ならびに組成物の作製方法および用途 | |
| JP5813641B2 (ja) | 凝固第ｉｘ因子組成物ならびにそれを製造および使用する方法 | |
| JP6300885B2 (ja) | 第Ｘａ因子阻害剤に対する抗体およびその使用の方法 | |
| CN102316893B (zh) | 因子Xa抑制剂的解毒剂及其与血液凝固剂组合使用的方法 | |
| RU2731507C1 (ru) | Gla домены в качестве нацеливающих агентов | |
| EP2022506B1 (en) | Method for the treatment of flavivirus infection, molecules and uses thereof | |
| JP2013502459A5 (enExample) | ||
| RU2010151725A (ru) | Аминокислотные последовательности, направленные против cхcr4 и других gpcr, и соединения, включаюшие их | |
| UA75064C2 (en) | Modified porcine factor viii and its therapeutic use | |
| TW200944218A (en) | Mutants of streptokinase and their covalently modified forms | |
| JP2010530238A5 (enExample) | ||
| CN116033927A (zh) | 从经修饰以表达因子viii的慢病毒载体的制剂中去除游离因子viii的方法 | |
| CN104379594B (zh) | 用于纯化重组因子Xa衍生物的方法 | |
| JP2024056926A (ja) | 第Ｘａ因子阻害剤に対する解毒剤 | |
| WO2004094476A3 (en) | Compositions and methods relating to stop-1 | |
| CN116194466A (zh) | 编码重组转化生长因子(TGF)-β单体的溶瘤病毒及其用途 | |
| York et al. | An antibody directed against the fusion peptide of Junin virus envelope glycoprotein GPC inhibits pH-induced membrane fusion | |
| Teçza et al. | Enzyme kinetic and binding studies identify determinants of specificity for the immunomodulatory enzyme ScpA, a C5a inactivating bacterial protease | |
| JP6469591B2 (ja) | 血液凝固第ｖｉｉ因子を含有する組成物におけるウイルス不活性化法 | |
| US20190100602A1 (en) | Anti-antithrombin single-domain antibodies and polypeptides comprising thereof | |
| Carle | Development of cyclic peptide inhibitors of coagulation factor XIa for safer anticoagulation | |
| Roddick | Fusing the C-terminal tridecapeptide of hirudin to α1-proteinase inhibitor M358R accelerates its rate of thrombin inhibition | |
| St Pierre | Identification and comparative analysis of novel factors from the venom gland of the coastal taipan (Oxyuranus scutellatus) and related species | |
| Swanson | Revisiting the antifibrinolytic effect of carboxypeptidase N: novel structure and regulation | |
| JPH03506039A (ja) | 転移防止性ペプチド |